Fatal fulminant Clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report
- 7 December 2019
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 26 (3) , 305-308
- https://doi.org/10.1016/j.jiac.2019.10.021
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development
This publication has 18 references indexed in Scilit:
- Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive peopleCochrane Database of Systematic Reviews, 2016
- Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?Journal of Medical Microbiology, 2015
- Kyoto global consensus report onHelicobacter pylorigastritisGut, 2015
- A case of severe pseudomembranous colitis diagnosed by colonoscopy after Helicobacter pylori eradicationClinical Journal of Gastroenterology, 2014
- Two cases of fulminant colitis due to binary toxin-positive Clostridium difficile that are not PCR ribotype 027 or type 078Journal of Medical Microbiology, 2013
- Pseudomembranous colitis associated with a triple therapy forHelicobacter pylorieradicationWorld Journal of Gastroenterology, 2013
- Clostridium difficile infection in Europe: a hospital-based surveyThe Lancet, 2011
- A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patientsJournal of Infection and Chemotherapy, 2010
- Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and EuropeThe Lancet, 2005
- Impact of Helicobacter pylori Infection on Gastric Cancer Incidence in a General Japanese PopulationArchives of internal medicine (1960), 2000